Skip to Main Content

With Everest Medicines’ $451 million listing now in the rear-view mirror, health care-focused CBC Group is paving the way for another portfolio company to IPO. But, first, a merger.

AffaMed Therapeutics announced last week that it is merging with EverInsight Therapeutics, another biopharmaceutical company. Both firms were founded by CBC, formerly known as C-Bridge Capital.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!